It took Kandaswamy (Swamy) Vijayan, CEO of newly launched Plexium Inc., a few years to figure out where he needed to focus his creative energies. With an engineering background, he helped develop diagnostic tools. But he wanted to take the skill further. "For longest time, I thought diagnostics were the be all and end all," Vijayan told BioWorld MedTech.
DUBLIN – Sofinnova Partners closed its ninth early stage venture capital fund, Sofinnova Capital IX, at €333 million (US$369 million) and is bringing the same playbook to bear on current investment opportunities that it has followed in the recent past.
PARIS – Incepto Medical SAS, of Paris, raised $6.2 million from three French venture capital funds – Axa Venture Partners, Bpifrance through its Patient Autonome Fund, and Cap Decisif – to develop its artificial intelligence (AI) medical imaging platform. "This funding round is a first step toward accelerating [the] rollout of our [AI] medical imaging solutions on a grand scale throughout France," Incepto CEO Antoine Jomier told BioWorld MedTech.
TORONTO – A total of $1.4 million in capital funding from 12 U.S., Canadian and European angel investors will help Toronto-based Cohesys Inc. complete preclinical animal studies, with an eye toward gaining approval for its nontoxic, adhesive tape for rebuilding facial bones.